News & Updates

Patients with radiographic axial spondyloarthritis (r-axSpA) who have been exposed to tumour necrosis factor inhibitor (TNFi) and interleukin (IL)-17 inhibitor (IL-17i) appear to have a lower risk of osteoporosis, but not hip fracture, than biologic disease-modifying antirheumatic drug (bDMARD)-naïve individuals, a recent study has shown.

Individuals with chronic hepatitis D (CHD) may benefit from lonafarnib boosted with ritonavir (LNF/RTV) alone or in combination with peg-interferon-alfa (PEG), findings from the phase III D-LIVR trial have shown.

Treatment with lutikizumab appears to improve outcomes in patients with moderate-to-severe hidradenitis suppurativa (HS) who have not responded to anti-TNF therapy, according to a phase II trial.

In Chinese postmenopausal women, adverse reproductive factors combined with unhealthy lifestyle behaviours appear to be associated with increased likelihood of cognitive decline, as reported in a study.

Tezepelumab demonstrates steroid-sparing potential in patients with severe asthma, reducing maintenance oral corticosteroid use while maintaining asthma control, as shown in the phase III SUNRISE study.

A recent study has emphasized the importance of early screening for chronic kidney disease (CKD) among patients with coronary artery disease (CAD). Both estimated glomerular filtration rate (eGFR) and urinary albumin/creatinine ratio (UACR) must be included in the test to provide a complete diagnosis.

The healthy versions of low-carbohydrate (LCD) and low-fat diets (LFD) appear to reduce the risk of coronary heart disease (CHD), suggests a study.